Skip to content

Advertisement

BMC Musculoskeletal Disorders

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis

  • Thomas Wilke1Email author,
  • Sabrina Mueller1, 2,
  • Sze Chim Lee1,
  • Istvan Majer3 and
  • Marieke Heisen3
BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201718:332

https://doi.org/10.1186/s12891-017-1684-0

Received: 12 January 2017

Accepted: 17 July 2017

Published: 2 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Jan 2017 Submitted Original manuscript
20 Feb 2017 Reviewed Reviewer Report - Johannes Nossent
25 Feb 2017 Reviewed Reviewer Report - James Galloway
27 Mar 2017 Author responded Author comments - Thomas Wilke
Resubmission - Version 2
27 Mar 2017 Submitted Manuscript version 2
9 May 2017 Author responded Author comments - Thomas Wilke
Resubmission - Version 3
9 May 2017 Submitted Manuscript version 3
Publishing
17 Jul 2017 Editorially accepted
2 Aug 2017 Article published 10.1186/s12891-017-1684-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
IPAM, University of Wismar
(2)
Ingress-health
(3)
Pharmerit International

Advertisement